Overview

Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO)

Status:
Completed
Trial end date:
2016-05-12
Target enrollment:
Participant gender:
Summary
This is a two part study comparing CHS-0214 to Enbrel in patients with chronic plaque PsO who have not yet received any biologic therapy for any indication (other than insulin or hormones).
Phase:
Phase 3
Details
Lead Sponsor:
Coherus Biosciences, Inc.
Collaborators:
Baxalta US Inc.
Shire
Treatments:
Etanercept